Mastek Q3FY26 Revenue at ₹905.7 Crore, Up 4.2% YoY; PAT Up 14.4% YoY
Mastek reported Q3FY26 revenue of ₹905.7 crore, up 4.2% YoY. PAT increased to ₹108.4 crore, up 14.4% YoY. Operating EBITDA margin was 16.1%. The company secured 26+ new AI deals and added 17 new clients. An interim dividend of ₹8 per share was declared. ESG score improved to 82/100.
The results show solid year-on-year growth in key financial metrics and a significant increase in the order backlog, indicating strong future revenue potential. The strategic focus on AI and the acquisition of new clients and significant deals suggest continued business expansion and market competitiveness.
The company reported year-on-year growth in revenue and profit, along with an increase in order backlog and a positive outlook on AI deals and client acquisition. The declaration of an interim dividend and improved ESG score further contribute to the positive sentiment.
Mastek Limited announced its unaudited financial results for the third quarter and nine months of FY26, ended December 31, 2025. The company reported a revenue from operations of ₹905.7 crore, a 4.2% increase year-on-year. Operating EBITDA margin stood at 16.1%, an increase of 60 basis points quarter-on-quarter. Profit After Tax (PAT) was ₹108.4 crore, up 11.2% quarter-on-quarter and 14.4% year-on-year. The total order backlog grew by 36.6% year-on-year, and the 12-month order backlog grew by 24.3% year-on-year in rupee terms.
Umang Nahata, Chief Executive Officer, commented on the results, noting a sequential revenue decline of 3.7% due to furloughs and planned project go-lives, but highlighted strong EBITDA growth and a robust pipeline. The company closed over 26 new AI deals and added 17 new clients during the quarter, bringing the total active clients to 333.
Deepak Kedia, Chief Financial Officer, mentioned the PAT margin expansion of 149 basis points and an increase in EPS to ₹34.7. Mastek declared an interim dividend of 160%, or ₹8 per share. The company's ESG performance improved significantly, with an S&P Global ESG CSA score of 82/100.
Key wins during the quarter included a three-year contract with a UK central government agency for a national biometrics platform, a deal with a UK-based financial statutory regulator, and engagements with a US-based global asset manager, an Australian local government, England's Healthcare System, a US-based global dental products company, a global Fortune 500 clinical research provider, a leading UK port, and a major American Fortune 500 recreational vehicle company. Mastek also received several recognitions, including from ISG, Everest, ET Making AI Work Awards, and Gartner.
What to do with a filing like this
Mastek Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.